NRD
CVS icon

Nebula Research & Development’s CVS Health CVS Stock Holding History

Nebula Research & Development’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-45,813
Closed -$3.16M – 235
2025
Q2 		$3.16M Buy
45,813
+1,400
+3% +$91.8K 0.27% 81
2025
Q1 		$3.01M Sell
44,413
-30,608
-41% -$1.83M 0.28% 83
2024
Q4 		$3.37M Buy
75,021
+57,263
+322% +$3.21M 0.4% 27
2024
Q3 		$1.12M Buy
+17,758
New +$1.04M 0.13% 258
2024
Q1 		– Sell
-6,061
Closed -$479K – 786
2023
Q4 		$479K Buy
+6,061
New +$431K 0.14% 267

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Nebula Research & Development's CVS Position: Q3 2025 in Review

Nebula Research & Development sold out of CVS Health (CVS) in Q3 2025, closing a stake of 45,813 shares — an estimated $3.16M sold.

Nebula Research & Development first reported a position in CVS in Q4 2023 and held it in 5 quarters. The position peaked at $3.37M in Q4 2024. 1,834 funds tracked by Wall St. Rank hold CVS as of Q3 2025.

  • Nebula Research & Development reported no remaining CVS Health position as of Q3 2025 after selling out during the quarter.
  • Nebula Research & Development sold 45,813 CVS Health shares in Q3 2025, an estimated $3.16M.
  • Nebula Research & Development first reported a position in CVS Health in Q4 2023 and held it in 5 quarters.
  • Nebula Research & Development's CVS Health position peaked at $3.37M in Q4 2024.
  • 1,834 funds tracked by Wall St. Rank held CVS Health as of Q3 2025.

Based on Nebula Research & Development's 13F filing for Q3 2025.